Literature DB >> 7640223

The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids.

R A Harris1, I D Hiles, M J Page, M J O'Hare.   

Abstract

The effects of expressing neu-T, a mutated constitutively activated form of c-neu, have been examined in the non-transformed conditionally immortalised human mammary luminal epithelial cell line, HB4a. A variant cell line, N4.1, which expressed neu-T, showed evidence of transformation, including partial loss of growth factor dependence and acquisition of anchorage-independent growth, but failed to give rise to tumours in nude mice, indicating that expression of neu-T alone was probably insufficient to cause tumorigenic progression to a full malignant phenotype. During characterisation of the N4.1 cell line, it was observed that under conditions of serum deprivation, it underwent apoptotic cell death, as demonstrated by light microscopy, flow cytometry and DNA gel electrophoresis. The induction of apoptotic cell death in the N4.1 cell line by serum deprivation was abrogated specifically by the addition of steroids with glucocorticoid activity but not any peptide growth factors studied. This study shows the induction of apoptosis by serum deprivation, and its abrogation by glucocorticoids occurring in human mammary luminal epithelial cells transformed by expression of neu-T, and implicates the involvement of receptor protein tyrosine kinases in an apoptotic signalling pathway in this cell type.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640223      PMCID: PMC2033972          DOI: 10.1038/bjc.1995.343

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  41 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  A simple and rapid method for detection of apoptosis in human cells.

Authors:  F Rösl
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods.

Authors:  M G Ormerod; M K Collins; G Rodriguez-Tarduchy; D Robertson
Journal:  J Immunol Methods       Date:  1992-08-30       Impact factor: 2.303

4.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

5.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis.

Authors:  G T Williams; C A Smith; E Spooncer; T M Dexter; D R Taylor
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

Review 6.  Apoptosis: mechanisms and roles in pathology.

Authors:  M J Arends; A H Wyllie
Journal:  Int Rev Exp Pathol       Date:  1991

7.  Abrogation of p53-mediated transactivation by SV40 large T antigen.

Authors:  K Segawa; A Minowa; K Sugasawa; T Takano; F Hanaoka
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

8.  Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.

Authors:  F Ciardiello; M Gottardis; F Basolo; S Pepe; N Normanno; R B Dickson; A R Bianco; D S Salomon
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

9.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

10.  Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting.

Authors:  M J O'Hare; M G Ormerod; P Monaghan; E B Lane; B A Gusterson
Journal:  Differentiation       Date:  1991-04       Impact factor: 3.880

View more
  7 in total

1.  Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing.

Authors:  C Victor Jongeneel; Christian Iseli; Brian J Stevenson; Gregory J Riggins; Anita Lal; Alan Mackay; Robert A Harris; Michael J O'Hare; A Munro Neville; Andrew J G Simpson; Robert L Strausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

2.  Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells.

Authors:  G C Huang; S Hobbs; M Walton; R J Epstein
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

Review 3.  Protecting the normal in order to better kill the cancer.

Authors:  Bingya Liu; Lewis Ezeogu; Lucas Zellmer; Baofa Yu; Ningzhi Xu; Dezhong Joshua Liao
Journal:  Cancer Med       Date:  2015-07-14       Impact factor: 4.452

4.  Expression of Estrogen Receptor-alpha in Nasal Polyps and the Effects of Dexamethasone on Estrogen Receptor-alpha Expression in RPMI 2650 Cells.

Authors:  Won Woo Ban; Yoon Jin Lee; Sang Han Lee; Jae Yeop Jung; Byoung Joon Baek
Journal:  J Korean Med Sci       Date:  2020-12-28       Impact factor: 2.153

Review 5.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

6.  TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.

Authors:  Benedicte Stavik; Grethe Skretting; Ole Kristoffer Olstad; Marit Sletten; Magnus Dehli Vigeland; Per Morten Sandset; Nina Iversen
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

7.  Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

Authors:  A Gandhi; P A Holland; W F Knox; C S Potten; N J Bundred
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.